Key Insights

Highlights

Success Rate

50% trial completion

Treatment Research

12 treatments under study, led by Cardiovascular Fixed Dose Combination Pill Acetylsalicylic Acid Simvastatin And Ramipril

Research Leaders

6 sponsors active, led by Ferrer Internacional S.A.

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 87/100

Termination Rate

40.0%

2 terminated out of 5 trials

Success Rate

50.0%

-36.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed with results

Key Signals

1 with results50% success

Data Visualizations

Phase Distribution

5Total
Not Applicable (3)
Phase 2 (2)

Trial Status

Completed2
Terminated2
Enrolling By Invitation1

Trial Success Rate

50.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (5)

Research Network

Common Treatments

  • Cardiovascular Fixed Dose Combination Pill Acetylsalicylic Acid Simvastatin And Ramipril2
  • Simvastatin2
  • Mind Plus Fb Intervention1
  • Control Rice Beverage1
  • Usual Care1

Active Sponsors

  • Ferrer Internacional S.A.2
  • PepsiCo Global R&D1
  • Tung Wah College1
  • United Arab Emirates University1
  • Glycemic Index Laboratories, Inc1

Top Investigators

Related Conditions

  • Pre Diabetes1
  • Cardiovascular Risk Factor1
  • High Blood Pressure1

Activity Timeline